There are also authors hypothesizing that DNMT3A/TET2 mutations represent a first hit, which is followed by a second hit in RHOA/IDH2 on the path for the pathogenesis of AITL [97]. This evidence concerns the gene IDH2 and angioimmunoblastic T-cell lymphoma.